ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
63,376.33
-0.81%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. UroGen Pharma Ltd (URGN)

  7. UroGen Pharma Ltd (URGN) 뉴스

URGN UroGen Pharma Ltd

14.30
0.04 (0.28%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
UroGen Pharma Ltd URGN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.04 0.28% 14.30 08:22:00
개장가 저가 고가 종가 전일 종가
14.50 14.14 14.70 14.30 14.26
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
05/05/202404:20BWUroGen Announces Results from ATLAS Showing Robust UGN-102..
05/05/202400:50BWNew Real-World Study on Retrograde Instillation of JELMYTO®..
03/05/202421:00BWUroGen Pharma to Report 2024 First Quarter Financial Results..
18/04/202401:02BWUroGen Announces New Data Presentations at the American..
15/04/202421:00BWUroGen Announces FDA Acceptance of Investigational New Drug..
03/04/202421:00BWUroGen Pharma Files Patent Infringement Action Against Teva..
14/03/202421:00BWUroGen Pharma Delivers Double Digit JELMYTO® Growth and..
08/03/202422:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
04/03/202422:00BWUroGen Pharma to Report Fourth Quarter and Full-Year 2023..
04/03/202421:00EDGAR2Form 8-K - Current report
01/03/202421:00EDGAR2Form 8-K - Current report
26/02/202422:00BWUroGen Pharma to Present at TD Cowen 44th Annual Health Care..
13/02/202407:47EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
08/02/202406:15EDGAR2Form 8-K - Current report
03/02/202409:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202409:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202409:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202409:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202400:13EDGAR2Form 144 - Report of proposed sale of securities
01/02/202423:53EDGAR2Form 144 - Report of proposed sale of securities
01/02/202422:00BWUroGen Pharma to Participate at Upcoming Investor..
24/01/202422:00BWUroGen Initiates Submission of a Rolling NDA to the FDA for..
18/01/202406:16EDGAR2Form 8-K - Current report
17/01/202422:00BWUroGen Secures Exclusive License from medac GmbH to Develop..
11/01/202422:00BWUroGen Pharma to Participate in the B. Riley Healthcare..
02/01/202422:04EDGAR2Form 8-K - Current report
09/12/202306:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
15/11/202306:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202322:00BWUroGen Pharma Reports Third Quarter 2023 Financial Results
13/11/202322:00BWUroGen will Present Scientific Advances in Bladder Cancer at..
07/11/202322:00BWUroGen Pharma to Report Third Quarter 2023 Financial Results..
03/10/202321:00BWFollowing Pre-NDA Meeting with the FDA, UroGen Announces..
12/09/202305:15EDGAR2Form 8-K - Current report
11/09/202320:00GLOBEEledon Pharmaceuticals Appoints Industry Veteran James..
09/09/202305:16EDGAR2Form S-3 - Registration statement under Securities Act of..
09/09/202304:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/09/202304:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/09/202304:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/09/202304:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/09/202304:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/09/202304:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/09/202304:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/09/202321:00BWUroGen Pharma Announces Inducement Grants Under Nasdaq..
06/09/202305:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/08/202321:00BWUroGen Pharma to Present at Upcoming Investor Conferences
10/08/202321:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202321:01EDGAR2Form 8-K - Current report
10/08/202321:00BWUroGen Pharma Reports Record JELMYTO Quarterly Sales and..
08/08/202321:00BWThe Journal of Urology Publishes Peer-Reviewed Article..
04/08/202321:56EDGAR2Form SC 13D - General statement of acquisition of beneficial..

최근 히스토리

NASDAQ
URGN
UroGen Pharma
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유